XOM is a HOLD at 66/100 after resolving a three-session failed-breakout pattern with a decisive breakout on October 23. The stock closed at $183.21, up 2.79% on the session, printed a fresh 52-week high of $183.75, and finished just 0.29% below that high at the 99.24th percentile of its 52-week range while the S&P 500 fell 0.52% and the Dow dropped 1.23%, roughly 3.3 percentage points of relative outperformance on a day when added 2.21% to 19.45 and the 10-year Treasury yield ticked back up 3.5 basis points to 4.988%. The breakout was confirmed by internals that had deteriorated the prior session: rose 11.49 million shares to a new series high of 596.34 million, the histogram re-expanded to 0.961 from 0.834 after four consecutive contractions from the October 16 peak of 1.380, and at 76.15 broke above the October 14 high of 74.92, negating the bearish divergence that had flagged the three prior sessions. The trend stack remains fully intact with price 22.23% above the at $149.89, 10.28% above the at $166.14, and 7.24% above the at $170.85. Fundamentals continue to improve: current-year of $13.29 is 20.0% above its 90-day-ago level of $11.08 and current-quarter of $4.033 is up 20.3% over 90 days and 7.1% in the last week, with seven and eight upward 30-day revisions against zero downward for the current and next fiscal years. The balance sheet is a fortress, with net debt of $31.78 billion equal to only 4.22% of the $753.34 billion market cap and $20.67 billion of free cash flow covering the 2.31% dividend at a 52.51% payout about 1.23x. The problem is price versus consensus: the $179.41 mean target now sits 2.07% BELOW the close and the $181.50 median is 0.93% below it, so the street must raise targets again or the stock has outrun its own coverage. Valuation offers no cushion at 23.58x trailing, 14.92x forward, 11.66x , and a 1.399 , while next-year consensus of $12.28 still embeds a 7.65% earnings decline from $13.29. The dominant near-term risk is the October 30 Q3 print, six days away, with the quarter's consensus marked up 20.3% over 90 days immediately after the June 30 quarter missed by 3.0% and with already at 76. Horizon view: HOLD over one month because a fresh entry at $183.21 into an earnings print with a raised bar and price above the mean target is poor risk/reward even though the breakout is genuine, BUY over six months on accelerating revisions and the confirmed accumulation trend, and HOLD over one year because a 14.9x forward multiple on declining next-year earnings leaves little room for commodity normalization.
投资判断
实时价格
$184.54
推荐分数
66%
66%
置信度
64%
64%
各期限展望
1个月
持有
短线
6个月
买入
中期
1年
持有
长期
核心催化
The October 30 Q3 earnings report, now six days out, is by far the most consequential near-term catalyst and it has become more binary, not less, after the breakout. Current-quarter consensus of $4.0327 has risen 20.3% over 90 days and 7.1% in the last week and next-quarter consensus has jumped 14.0% in a single week to $3.8777, so the company must beat a freshly elevated bar immediately after the June 30 quarter missed by 3.0%, with the stock already trading above its $179.41 mean target. A beat plus constructive guidance would likely force another round of target increases toward the $185-$206 band and extend the breakout; a miss or soft guidance would leave the shares above consensus with at 76 and no stop protection against an overnight gap, which is precisely the asymmetry that caps the near-term rating at HOLD.
Limit exposure to roughly 50-60% of normal size ahead of the October 30 report and avoid initiating a full position at $183.21 after a 12.99% one-month run left the shares above their own mean analyst target. at 19.45 still sits inside the Neutral band and permits standard sizing in principle, but the combination of a raised earnings bar (current-quarter consensus +20.3% over 90 days, next-quarter +14.0% in one week), a 3.0% miss in the most recent reported quarter, at 76.15, price 2.07% above the mean target, and breakout volume of only 1.01x the 20-day average justifies a reduced footprint until the print is cleared or a retest of the $180.31 breakout level appears. Existing holders should let the position run with a defined stop rather than compound into the event.
投资逻辑快照
什么情况涨
The strongest case for owning XOM is that the one technical objection from the prior run has been eliminated while the fundamental revision cycle keeps accelerating. The $180.26-$180.31 triple-top that capped the stock on October 20, 21, and 22 was cleared decisively on October 23: XOM closed at $183.21, up 2.79%, printed a new 52-week high of $183.75, and did it while the S&P 500 fell 0.52% and the Dow fell 1.23%, roughly 3.3 percentage points of relative outperformance on a day when rose 2.21% to 19.45. Crucially, the internals that had deteriorated the day before reversed in the same direction: rose 11.49 million shares to a new series high of 596.34 million, the histogram re-expanded to 0.961 from 0.834 after four contraction sessions, and at 76.15 broke above the October 14 peak of 74.92, which retires the bearish divergence rather than confirming it. Earnings power keeps being repriced upward faster than the share price: current-quarter of $4.0327 is 20.3% above its 90-day-ago level and 7.1% higher in a week, next-quarter of $3.8777 jumped 14.0% in a week, current-year of $13.2926 is 20.0% above 90 days ago, and next-year of $12.2762 is 16.2% above 90 days ago, with three upward and zero downward revisions in the last seven days across every horizon and seven versus zero and eight versus zero over 30 days. The sell-side is chasing rather than leading: Barclays lifted to $200 from $177 on October 19 and Morgan Stanley to $185 from $177 on October 15, with the street high now at $206. The company beat five of six supplied quarters, generated $59.73 billion of operating cash flow and $20.67 billion of free cash flow, and carries net debt of just $31.78 billion against a $753.34 billion market cap, funding a 2.31% dividend at a comfortable 52.51% payout. The relative-value case remains intact with XOM at roughly 12.9x forward earnings per the supplied DataTrek figures against a 19.2x S&P 500 multiple. Scoreboard accountability from the prior run: the $171-$176 entry zone was validated repeatedly (October 12 low $171.01, October 15 low $173.60, October 20 low $174.92, October 21 low $176.15, October 22 low $174.63), the $167.00 stop was never threatened, and the $185-$200 exit zone was not reached (high $180.31) before the breakout, meaning the disciplined plan worked and the breakout now justifies a higher stop and a higher exit band.
什么情况跌
The strongest argument against owning XOM at $183.21 is that the stock has just spent its entire sell-side cushion six days before a binary earnings event. The $179.41 mean target is now 2.07% below the close and the $181.50 median is 0.93% below it, so every analyst who is going to capitulate upward has to do it in the next week, and 16 of 25 rated analysts already say Hold with only 3 Strong Buy and zero Sell. (14) at 76.15 is the most overbought reading since October 14, price is 22.23% above the and 12.99% higher in a month, and the breakout bar drew just 1.01x the 20-day average volume and 0.90x the 60-day average, which is thin confirmation for a 52-week-high breakout and is exactly the kind of move that retraces when the catalyst disappoints. The earnings bar has been raised twice in two weeks on top of a 3.0% miss in the most recent reported quarter: current-quarter consensus of $4.0327 is up 20.3% over 90 days and 7.1% in the last week, next-quarter consensus jumped 14.0% in a single week, and next-year consensus of $12.28 still implies a 7.65% earnings decline from $13.29, so the revision cycle is a commodity-tailwind mark-up into a normalization year, not a durable growth curve. Investors are paying 23.58x trailing and 14.92x forward earnings for that declining next-year number, plus 11.66x when the supplied Zacks comparison puts trailing at 9.07x against a 5.81x industry average, and the 2.74% free-cash-flow yield and 2.31% dividend yield are thin compensation against a 4.988% risk-free 10-year Treasury. Macro is not helping either: at 19.45 sits at the top of the Neutral band, the S&P 500 and Dow both closed lower on October 23, and the 10-year yield rose 3.5 basis points, so the day's relative strength may prove to be a one-session rotation rather than a durable regime shift. The short thesis is straightforward: a demand-driven oil pullback or geopolitical de-escalation removes the supply premium, estimates roll back toward the $10.5623 level of 90 days ago (14.0% below current next-year consensus), and a 14.9x forward multiple compresses toward the industry average. Short interest at 1.07% of float with a 2.75-day ratio means bears are not crowded, so there is no squeeze to catch a falling stock, and all five supplied news items are 24 days stale, meaning the entire 12.99% monthly gain has occurred without documented fresh company-specific information.
A daily close below $173.00 would break beneath the October 22 low of $174.63 and the October 20 low of $174.92 and return price inside the pre-breakout October range, invalidating the October 23 breakout and requiring an exit; separately, a Q3 print on October 30 that misses the $4.0327 consensus or guides next-quarter below the $3.8777 consensus would invalidate the estimate-revision thesis even if the chart subsequently held.
Commodity normalization: next-year consensus of $12.2762 already implies a 7.65% decline from the current-year $13.2926, and supplied September coverage described WTI retreating from above $100 to above $90; a demand shock or easing of geopolitical supply risk could push estimates back toward the $10.5623 level of 90 days ago, roughly 14.0% below the current next-year consensus.
Price above consensus with asymmetric targets: at $183.21 the $179.41 mean target implies 2.07% downside and the $181.50 median implies 0.93% downside, while the $142 low target implies about 22.49% downside against roughly 12.44% upside to the $206 high, and the stock trades at 23.58x trailing earnings, 14.92x forward, and 11.66x versus a supplied 5.81x industry comparison.
Earnings execution risk on October 30: current-quarter consensus of $4.0327 rose 20.3% over 90 days and 7.1% in the last week, next-quarter consensus rose 14.0% in a single week to $3.8777, the June 30 quarter already missed by 3.0%, and no updated operational status (including outage, turnaround, or realized-price effects) is included in this bundle, so a modest shortfall would be amplified by the raised bar and by at 76.15.
Breakout quality and reversion risk: October 23 volume of 11.49 million shares was only 1.01x the 20-day average and 0.90x the 60-day average, has risen to $3.885 (2.12% of price) from $3.454 on October 14, and 20-day realized volatility climbed to 17.88%, so the move is extended and thinly confirmed.
Macro regime risk: at 19.45 sits at the top of the Neutral band after a 2.21% rise and the 10-year yield ticked up 3.5 basis points to 4.988% on October 23, so a modest further shock pushes the regime into Risk-Off and typically forces de-risking across all equity exposure regardless of relative strength.
Long-cycle project execution: Rovuma's planned first phase of 18.6 million tonnes per year and eventual 40-plus million tonne ambition have no final investment decision or quantified return profile in the bundle, so delays, cost inflation, or weaker contract economics would reduce the value of the LNG optionality that partially supports the multiple.
Information staleness: all five supplied news items are dated September 29 and are 24 days old against the October 23 run, so the 12.99% one-month advance and the breakout to $183.75 occurred without documented fresh company-specific support and any pre-earnings update could invalidate the current narrative.
接下来关注
下一次财报：2026年10月30日
The October 30 Q3 earnings report, now six days out, is by far the most consequential near-term catalyst and it has become more binary, not less, after the breakout. Current-quarter consensus of $4.0327 has risen 20.3% over 90 days and 7.1% in the last week and next-quarter consensus has jumped 14.0% in a single week to $3.8777, so the company must beat a freshly elevated bar immediately after the June 30 quarter missed by 3.0%, with the stock already trading above its $179.41 mean target. A beat plus constructive guidance would likely force another round of target increases toward the $185-$206 band and extend the breakout; a miss or soft guidance would leave the shares above consensus with at 76 and no stop protection against an overnight gap, which is precisely the asymmetry that caps the near-term rating at HOLD.
信号仪表盘
决策输入
6 个信号
基本面
-2.1%
距分析师均值目标空间
At $183.21 with a $753.34 billion market cap and a $791.85 billion enterprise value, XOM trades at 23.58x trailing earnings, 14.92x forward earnings, a 1.399 , 2.90x book, 2.09x sales, 11.66x , a 2.74% free-cash-flow yield, and a 2.31% dividend yield. The sits below the generic 1.5x threshold, but is a misleading tool for a commodity-linked earnings base, especially when the forward curve itself embeds a 7.65% decline from $13.29 to $12.28. A supplied Zacks article cites trailing of 9.07x against a 5.81x industry average on a different calculation basis; it is not directly comparable to the database's 11.66x, but both readings point to a premium to peers rather than a discount. Target arithmetic has now inverted from support to resistance: after a 2.79% single-session gain, the $179.41 mean target implies 2.07% DOWNSIDE, the $181.50 median implies 0.93% downside, the $206 street high still implies about 12.44% upside, and the $142 low target implies roughly 22.49% downside, with the $64 spread equal to about 34.9% of the share price. The one genuinely supportive valuation datapoint remains relative: a supplied DataTrek analysis places XOM at roughly 12.9x forward estimates against a 19.2x S&P 500 market multiple, supporting an energy-versus-index allocation bid even if the stock is expensive versus its own industry. The Simply Wall St DCF piece argues intrinsic value above a $162.52 reference price, but that reference is now 12.73% stale against $183.21 and the article is promotional in tone. The conclusion is fairly valued to modestly expensive with no margin of safety, and the recent cluster of raised targets has been fully absorbed by the share price.
技术面
Strongly Bullish
趋势质量
At $183.21, price sits about 22.23% above the at $149.89, 10.28% above the at $166.14, and 7.24% above the at $170.85. The is roughly 10.84% above the and the is 2.84% above the , an established bullish stack with no crossover risk in either direction. The October 23 session decisively resolved the failed-breakout pattern that had built over three sessions: the stock opened at $179.37, ran to a new 52-week high of $183.75, and closed at $183.21, just 0.29% below the high and 1.61% above the prior ceiling of $180.31 that had rejected price on October 20, 21, and 22. That converts $180.26-$180.31 from resistance into the first support shelf. The trend is a strong, intact uptrend at the 99.24th percentile of its 52-week range, but the 22.23% extension above the and the 12.99% one-month return mean the move is now late-stage in the short term and vulnerable to mean reversion on any disappointment.
财报
6天
Improving
The most recent supplied quarter, ending June 30, 2026, reported of $3.52 versus $3.62887 consensus, a 3.0% miss and the only miss in the six supplied quarters; of the five beats, four were small (1.12%, 1.16%, 3.03%, 4.93%) and one was an outlier at 107.46%, so the 23.5% average surprise is distorted and the roughly 3.0% median beat is the more informative figure, and neither formal guidance nor post-report share reaction is included in this bundle.
新闻
Mixed-Bullish
新闻基调
The October 30 Q3 earnings report, now six days out, is by far the most consequential near-term catalyst and it has become more binary, not less, after the breakout. Current-quarter consensus of $4.0327 has risen 20.3% over 90 days and 7.1% in the last week and next-quarter consensus has jumped 14.0% in a single week to $3.8777, so the company must beat a freshly elevated bar immediately after the June 30 quarter missed by 3.0%, with the stock already trading above its $179.41 mean target. A beat plus constructive guidance would likely force another round of target increases toward the $185-$206 band and extend the breakout; a miss or soft guidance would leave the shares above consensus with at 76 and no stop protection against an overnight gap, which is precisely the asymmetry that caps the near-term rating at HOLD.
宏观
Neutral
4.99% 10Y / 19.5 VIX
at 19.45 sits at the very top of the Neutral 15-20 band after a 2.21% rise, one shock away from a Risk-Off downgrade, and the 10-year yield ticking back up 3.5 basis points to 4.988% normally penalizes long-duration cash flows, yet XOM rose 2.79% while the S&P fell 0.52% and the Dow fell 1.23%, evidence that capital is rotating into cash-generative real assets as a volatility hedge rather than punishing the sector for higher rates.
稳定性
Cyclical Upside
Core Anchor
ExxonMobil is the highest-quality integrated major available: upstream, downstream, and chemicals are all scaled, Permian and Guyana barrels sit low on the cost curve, and the balance sheet is a source of strength rather than a constraint with debt-to-equity of 15.92% and net debt of $31.78 billion equal to only 4.22% of the $753.34 billion market cap. Operating cash flow of $59.73 billion and free cash flow of $20.67 billion cover a roughly $16.8 billion dividend outlay (2.31% yield, 52.51% payout) about 1.23x, which is what makes the distribution defensible through a downcycle. It belongs in Cyclical Upside rather than a compounder bucket because earnings are commodity-linked and next-year consensus of $12.28 already embeds a 7.65% decline from the current-year $13.29; the reported 0.209 beta badly understates practical risk, so use the 17.88% 20-day realized volatility and at 2.12% of price as the real risk references. XOM should anchor a dedicated energy sleeve rather than substitute for a defensive bond proxy, and holders should expect 25-40% peak-to-trough drawdowns in a genuine oil-cycle downturn even though the franchise itself is durable.
分析师目标区间
均值目标
$179.41
高低目标
$142 / $206
分析师中值目标
$181.50
共识区间
$142 - $206
— 位分析师
Mean
$142$179$206
市场共识
After the October 23 breakout to $183.21, the $179.41 mean target implies 2.07% downside and the $181.50 median implies 0.93% downside, so consensus has flipped from thin support to a mild headwind and most of the street is now chasing rather than leading the price. The $64 range between the $142 low and the $206 high equals roughly 34.9% of the share price, an unusually wide dispersion that reflects genuine disagreement about the durability of current crude and refining economics. The 25-rating distribution of 3 Strong Buy, 6 Buy, and 16 Hold is dominated by Holds and contains no Sell, and the number_of_analysts field is null so breadth-adjusted conviction cannot be computed. The bullish read is direction of travel: Barclays at $200 and Morgan Stanley at $185 both raised targets inside the last ten days, and any further mark-ups would restore a positive target-versus-price gap; the bearish read is that a stock trading above its own mean target six days before earnings is priced for a beat that has already been written into estimates.
筹码脉冲
内部人信号
Neutral
净偏向
No recent activity
内部人持股
0.1%
机构持股
67.2%
解读
The single malformed, unclassifiable filing provides no usable evidence of management's near-term confidence, and insider ownership of just 0.082% offers little additional alignment signal, so insider activity should be treated as a neutral non-factor in this thesis.
重要活动
The only supplied Form-4 record names Chief Executive Officer Darren W. Woods with 225,000 direct shares, but the date field is malformed as "62", the transaction type is blank, and the transaction value is null, so the filing cannot be classified as an open-market purchase, a discretionary sale, a grant, or a pre-scheduled 10b5-1 transaction. There is no second filing in the bundle and therefore no cumulative pattern to interpret.
市场背景
行业
Oil & Gas Integrated
Mixed-Bullish
情绪
21
跟踪股票
2
分组
industry
Oil & Gas Integrated 行业 当前情绪为 Mixed-Bullish，板块平均评分约 66 分，资金偏好与评分正在走弱，且leadership is concentrated in CVX。
Crude Supply Security and Geopolitical Oil Premium
评分: 38
Bullish
Supplied coverage reported WTI above $90 per barrel after a retreat from above $100 and tied the geopolitical supply premium in the Persian Gulf directly to upstream economics for Exxon's low-cost Permian and Guyana barrels. The rotation evidence has now confirmed itself: on October 23 XOM rose 2.79% to a new 52-week high of $183.75 while the S&P 500 fell 0.52%, the Dow fell 1.23%, and rose 2.21% to 19.45, indicating capital moving decisively into real assets and cash-generative energy rather than merely defensively. The narrative remains constructive for earnings but fragile, since a demand shock or a geopolitical de-escalation would remove the price premium quickly, and the commodity input in this bundle is 24 days stale and should be re-checked before the print.
The October 23 breakout flipped relative strength from a one-day curiosity into a confirmed trend, with XOM outperforming a 0.52% S&P 500 decline by roughly 3.3 percentage points and clearing the $180.31 ceiling that had rejected it three times.
XOM rose 2.79% to $183.21 on October 23 while the S&P 500 fell 0.52%, the Dow fell 1.23%, the Nasdaq fell 0.21%, and the Russell 2000 fell 0.29%, a broad-index underperformance pattern that points to sector-specific capital inflow.
on XOM rose 11.49 million shares to a new series high of 596.34 million, confirming that the breakout was accompanied by cumulative accumulation rather than short covering.
September 29 coverage reported WTI above $90 after a retreat from above $100, highlighted low-cost Permian and Guyana breakevens, and named Chevron and ConocoPhillips as peer beneficiaries; the commodity input is 24 days stale and should be re-checked before the print.
A supplied DataTrek analysis frames XOM at roughly 12.9x forward earnings per FactSet versus a 19.2x S&P 500 market multiple, supporting a relative-value bid for energy versus index-level valuation.
LNG Capacity Build-Out and Energy Security
评分: 26
Mixed-Bullish
The OneSubsea subsea production systems award for Rovuma phase one, layered on roughly $1.1 billion of August pre-investment contracts and the Saipem-Jan De Nul upstream award, converts what was a headline ambition into a sequence of dated, committed work packages for a planned 18.6 million tonnes per year first phase built around 12 liquefaction modules and an initial 18 subsea well program. Exxon has guided that the broader development could support more than 40 million tonnes per year, establishing a long-duration growth option for an otherwise mature production base. No final investment decision or quantified project return is included in the bundle, so this is strategic optionality rather than an underwritable near-term cash flow, and it does nothing to move the next two quarterly prints; the 10-year yield ticking back up 3.5 basis points to 4.988% is a marginal headwind to the present value of these long-dated cash flows.
The subsea award names a specific supplier and scope for the first phase, another concrete milestone on the path to final investment decision and incremental evidence for the energy-security narrative that supports the multi-year multiple, though the story requires a post-earnings window to matter to the share price.
The OneSubsea contract covers trees, manifolds, umbilicals, and control systems plus engineering, procurement, manufacturing, and installation, with a planned service base in Mozambique for local training and regional supply chains.
The roughly $1.1 billion of August pre-investment contracts and the Saipem-Jan De Nul consortium selection show cumulative capital commitments advancing toward FID without an announced sanction date.
The bundle's own DCF commentary cites approval of the Rose carbon-capture project in Texas as a reason analysts extend cash-flow forecasts beyond the near term, indicating that lower-carbon and LNG project milestones are being capitalized into long-run valuation work.
The 10-year Treasury yield at 4.988% remains a demanding discount rate for 2030s-vintage LNG cash flows, and the 3.5 basis point rise on October 23 removes some of the relief seen the prior session.
关键指标
23 项指标
市值
$753.34B
市盈率 (TTM)
23.6
远期市盈率
14.9
营收增速
44.1%
净资产收益率
12.6%
Beta 系数
0.21
完整指标集
另外 17 项指标
估值结构
估值倍数与现金流框架。
市销率
2.1
市净率
2.9
企业价值 / EBITDA
11.7
质量与资产负债表
利润率、杠杆与流动性。
毛利率
29.8%
营业利润率
15.9%
资产负债率
15.9
流动比率
1.13x
速动比率
0.80x
仓位与价格区间
空头仓位与52周区间位置。
流通盘空头占比
1.1%
空头回补天数
2.75x
52周最高
$183.75
52周最低
$112.51
距52周高点
-0.3%
距52周低点
62.8%
公司分类
板块与行业背景。
板块
Energy
行业
Oil & Gas Integrated
其他信号
自由现金流
$20671000576.00
详细分析
估值
At $183.21 with a $753.34 billion market cap and a $791.85 billion enterprise value, XOM trades at 23.58x trailing earnings, 14.92x forward earnings, a 1.399 , 2.90x book, 2.09x sales, 11.66x , a 2.74% free-cash-flow yield, and a 2.31% dividend yield. The sits below the generic 1.5x threshold, but is a misleading tool for a commodity-linked earnings base, especially when the forward curve itself embeds a 7.65% decline from $13.29 to $12.28. A supplied Zacks article cites trailing of 9.07x against a 5.81x industry average on a different calculation basis; it is not directly comparable to the database's 11.66x, but both readings point to a premium to peers rather than a discount. Target arithmetic has now inverted from support to resistance: after a 2.79% single-session gain, the $179.41 mean target implies 2.07% DOWNSIDE, the $181.50 median implies 0.93% downside, the $206 street high still implies about 12.44% upside, and the $142 low target implies roughly 22.49% downside, with the $64 spread equal to about 34.9% of the share price. The one genuinely supportive valuation datapoint remains relative: a supplied DataTrek analysis places XOM at roughly 12.9x forward estimates against a 19.2x S&P 500 market multiple, supporting an energy-versus-index allocation bid even if the stock is expensive versus its own industry. The Simply Wall St DCF piece argues intrinsic value above a $162.52 reference price, but that reference is now 12.73% stale against $183.21 and the article is promotional in tone. The conclusion is fairly valued to modestly expensive with no margin of safety, and the recent cluster of raised targets has been fully absorbed by the share price.
资产负债表
Debt-to-equity of 15.92% (about 0.16x) is conservative for a capital-intensive integrated producer. Cash of $10.59 billion against total debt of $42.37 billion leaves net debt of $31.78 billion, only about 4.22% of market capitalization; operating cash flow covers total debt 1.41x while cash covers total debt only 0.25x. Free cash flow of $20.67 billion on $59.73 billion of operating cash flow implies roughly 34.6% conversion after an implied capital-spending burden of about $39.06 billion, enough to fund the roughly $16.8 billion dividend outlay about 1.23x and still leave residual cash for growth capital. Current and quick ratios of 1.13 and 0.80 are adequate but not generous, and coverage remains hostage to crude prices and refining margins. On any reasonable oil scenario above $70 Brent the balance sheet is a source of strength rather than a constraint, and the 2.31% yield is not at risk from leverage.
增长
Trailing revenue growth of 44.1% and earnings growth of 112.8% reflect favorable commodity economics and easy comparisons rather than a durable organic growth rate and should not be extrapolated. The forward estimate path is the more useful guide and it accelerated again this week: current-quarter of $4.0327 is 20.3% above its 90-day-ago level of $3.3524 and 7.1% above the level of seven days ago, next-quarter of $3.8777 is 34.8% above its 90-day-ago level of $2.8762 and 14.0% above seven days ago, current-year of $13.2926 is 20.0% above 90 days ago ($11.0760) and 6.0% above seven days ago, and next-year of $12.2762 is 16.2% above 90 days ago ($10.5623) and 5.8% above seven days ago. The critical nuance is that next-year consensus still implies a 7.65% earnings decline from $13.29 to $12.28, so the revision cycle is raising estimates into a normalization year rather than establishing a new growth trajectory. Gross margin of 29.77%, operating margin of 15.86%, margin of 18.82%, and net margin of 9.07% are solid for an integrated major, but the bundle contains no multi-year margin series to establish sustained expansion. Permian optimization, Guyana, and Rovuma LNG are longer-duration options whose near-term earnings contribution is not quantified in this bundle.
生意质量
The integrated upstream, downstream, and chemicals footprint plus low-cost Permian and Guyana positions give Exxon a structurally stronger franchise than a pure-play producer, and the 29.77% gross margin, 15.86% operating margin, 18.82% margin, and 9.07% net margin confirm real operating leverage. of 12.58% and of 5.52% are respectable for an asset-heavy business but do not justify an unlimited multiple. Liquidity is workable rather than abundant at a 1.13 current ratio and 0.80 quick ratio. Institutional ownership of 67.24% and insider ownership of 0.082% mean governance is dominated by institutions with minimal management skin in the game. Short interest at 1.07% of float with a 2.75-day short ratio is not a crowded bear position, although no time series is supplied to determine direction. The reported 0.209 beta is a poor risk gauge; 17.88% 20-day realized volatility and at 2.12% of price are the practical references, and average daily dollar volume of about $1.95 billion over the last 20 sessions means position size is limited by conviction rather than liquidity.
资本配置
Operating cash flow of $59.73 billion and free cash flow of $20.67 billion comfortably cover the dividend, which at a 2.31% yield and 52.51% payout consumes roughly $16.8 billion annually at the current share count of 4.1119 billion. The remaining free cash flow plus balance-sheet capacity funds the growth program, including Guyana, Permian optimization, the Rose carbon-capture project in Texas, and the Rovuma LNG pre-investment spend that has already included roughly $1.1 billion of August long-lead contracts, a Saipem-Jan De Nul upstream award, and the October OneSubsea subsea production systems selection. No historical share-count or repurchase series is supplied, so buyback accretion versus dilution cannot be quantified; the bundle only provides 4.1119 billion shares outstanding against 4.1038 billion float, a snapshot rather than a trend. Capital deployment appears disciplined and balance-sheet funded rather than debt-funded, which preserves shareholder value, but Rovuma remains pre-FID with no disclosed return profile, so a portion of long-cycle spending is still unproven optionality.
预期修正
Revision momentum is unambiguously positive and strengthened again this week, with every horizon showing upward revisions against zero downward revisions in the last seven days. Current-quarter of $4.0327 rose from $3.7654 seven days ago and $3.3524 ninety days ago, with two upward and zero downward revisions in the last seven days and three upward against one downward in the last 30 days. Next-quarter of $3.8777 rose from $3.4002 seven days ago, a 14.0% weekly jump, against $2.8762 ninety days ago. Current-year of $13.2926 rose from $12.5419 seven days ago and $11.0760 ninety days ago, with three upward and zero downward revisions in the last week and seven upward and zero downward in 30 days. Next-year of $12.2762 rose from $11.6030 seven days ago and $10.5623 ninety days ago, with three upward and zero downward revisions in the last week and eight upward and zero downward in 30 days. The itemized action list is more informative than the aggregate counters, which report zero upgrades and zero downgrades despite visible changes: Barclays maintained Overweight and raised its target to $200 from $177 on October 19, Morgan Stanley maintained Overweight and raised to $185 from $177 on October 15, TD Cowen maintained Buy and raised to $180 from $168 on September 28, and Piper Sandler maintained Neutral and raised to $185 from $158 on September 3, while Wells Fargo cut to Equal-Weight from Overweight on October 1 with a $182 target. The recommendation mix slipped marginally worse over the month (3/7/15 to 3/6/16 Strong Buy/Buy/Hold), consistent with rising price targets but a diminishing willingness to recommend at these levels.